Repligen Corp risk profile

48 Elevated one input has moved against it

Measured 21 October 2026 from RGEN's filed statements. Recomputed nightly.

48 (Elevated), driven by Competitive position at 75, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation37NormalVolatileOne-year price volatility — 47.1%
Operating pressure38NormalEasingOperating-margin drift — -20.6 percentage points
Cash conversion14ContainedStableCapital spending against operating cash — 0.20x
Leverage and coverage14ContainedEasingInterest cover — 6.22x
Competitive position75StretchedStableRevenue-growth gap against peers — -37.9 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Repligen Corp